The interaction of the von Hippel-Lindau tumor suppressor and heterochromatin protein 1
- 15 February 2012
- journal article
- Published by Elsevier BV in Archives of Biochemistry and Biophysics
- Vol. 518 (2), 103-110
- https://doi.org/10.1016/j.abb.2011.12.023
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- A guided tour of the Trans‐Proteomic PipelineProteomics, 2010
- Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genesNature, 2010
- VHL Mutations Linked to Type 2C von Hippel-Lindau Disease Cause Extensive Structural Perturbations in pVHLOnline Journal of Public Health Informatics, 2009
- Novel exon 12 mutations in the HIF2A gene associated with erythrocytosisBlood, 2008
- A Gain-of-Function Mutation in theHIF2AGene in Familial ErythrocytosisThe New England Journal of Medicine, 2008
- pVHL Acts as an Adaptor to Promote the Inhibitory Phosphorylation of the NF-κB Agonist Card9 by CK2Molecular Cell, 2007
- The von Hippel–Lindau protein, HIF hydroxylation, and oxygen sensingBiochemical and Biophysical Research Communications, 2005
- Genetic Analysis of Pathways Regulated by the von Hippel-Lindau Tumor Suppressor in Caenorhabditis elegansPLoS Biology, 2004
- Empirical Statistical Model To Estimate the Accuracy of Peptide Identifications Made by MS/MS and Database SearchAnalytical Chemistry, 2002
- Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central EuropeHuman Genetics, 1996